Anna S. Bader

Anna S. Bader

Auto-generated profile, based on publicly available information

Anna S. Bader

Department of Radiology & Biomedical Imaging, Yale University School of Medicine, New Haven, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2024 in Chest
Verified
Journal Article
Closed access
FDFrank C. Detterbeck
Frank C. Detterbeck
GWGavitt A. Woodard
Gavitt A. Woodard
ABAnna S. Bader
Anna S. Bader
SDSanja Dacic
Sanja Dacic
MGMichael J. Grant
Michael J. Grant
LTLynn T. Tanoue
Lynn T. Tanoue

1 October 2020 in RadioGraphics
Verified
Journal Article
Closed access
MRMargarita V. Revzin
Margarita V. Revzin
SRSarah Raza
Sarah Raza
RWRobin Warshawsky
Robin Warshawsky
CDCatherine D’agostino
Catherine D’agostino
NSNeil C. Srivastava
Neil C. Srivastava
JPJohn S. Pellerito
John S. Pellerito
With the growing global COVID-19 outbreak, it is essential for radiologists to understand the viral pathogenesis and the diagnostic imaging hallmarks and varied pathologic manifestations of this in... Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in coronavirus disease 2019 (COVID-19), which was declared an official pandemic by the World Health Organization ...

1 November 2020 in RadioGraphics
Verified
Journal Article
Closed access
MRMargarita V. Revzin
Margarita V. Revzin
SRSarah Raza
Sarah Raza
NSNeil C. Srivastava
Neil C. Srivastava
RWRobin Warshawsky
Robin Warshawsky
CDCatherine D’aGostino
Catherine D’aGostino
JPJohn S. Pellerito
John S. Pellerito
In part 2 of this two-part review article, the extrapulmonary imaging manifestations of coronavirus disease 2019 (COVID-19), as well as the pediatric and pregnancy-related manifestations of the vir... Infection with severe acute respiratory syndrome coronavirus 2 results in coronavirus disease 2019 (COVID-19), which was declared an official pandemic by the World Health Organization on March 11, ...

19 August 2022 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
AWAxel Wismüller
Axel Wismüller
ADAdora M. Dsouza
Adora M. Dsouza
AAAnas Z. Abidin
Anas Z. Abidin
MVM. Ali Vosoughi
M. Ali Vosoughi
CGChristopher Gange
Christopher Gange
ABAnna S. Bader
Anna S. Bader
We introduce a multi-institutional data harvesting (MIDH) method for longitudinal observation of medical imaging utilization and reporting. By trackingbothlarge-scale utilizationandclinical imaging results data, the MIDH approach is targeted at measuring surrogates for important disease-related observational quantities over time. To quantitatively investigate its clinical applicability, we performed a retrospective multi-institutional study encompassing 13 healthcare systems throughout the United States before and after the 2020 COVID-19 pandemic. Using repurposed software infrastructure of a commercial AI-based image analysis service, we harvested data on medical imaging service requests and radiology reports for 40,037 computed tomography pulmonary angiograms (CTPA) to evaluate for pulmonary embolism (PE). Specifically, we compared two 70-day observational periods, namely (i) a pre-pandemic control period from 11/25/2019 through 2/2/2020, and (ii) a period during the early COVID-19 pandemic from 3/8/2020 through 5/16/2020. Natural language processing (NLP) on final radiology reports served as the ground truth for identifying positive PE cases, where we found an NLP accuracy of 98% for classifying radiology reports as positive or negative for PE based on a manual review of 2,400 radiology reports. Fewer CTPA exams were performed during the early COVID-19 pandemic than during the pre-pandemic period (9806 vs. 12,106). However, the PE positivity rate was significantly higher (11.6 vs. 9.9%,p < 10−4) with an excess of 92 PE cases during the early COVID-19 outbreak, i.e., ~1.3 daily PE cases more than statistically expected. Our results suggest that MIDH can contribute value as an exploratory tool, aiming at a better understanding of pandemic-related effects on healthcare.

1 August 2024 in RadioGraphics
Verified
Journal Article
Closed access
BGBabina Gosangi
Babina Gosangi
ISIrene Dixe de Oliveira Santo
Irene Dixe de Oliveira Santo
AKAbhishek Keraliya
Abhishek Keraliya
YWYifan Wang
Yifan Wang
DIDavid Irugu
David Irugu
ABAnna S. Bader
Anna S. Bader
Li-Fraumeni syndrome (LFS) is a rare autosomal dominant familial cancer syndrome caused by germline mutations of the tumor protein p53 gene (TP53), which encodes the p53 transcription factor, also known as the "guardian of the genome." The most common types of cancer found in families with LFS include sarcomas, leukemia, breast malignancies, brain tumors, and adrenocortical cancers. Osteosarcoma and rhabdomyosarcoma are the most common sarcomas. Patients with LFS are at increased risk of developing early-onset gastric and colon cancers. They are also at increased risk for several other cancers involving the thyroid, lungs, ovaries, and skin. The lifetime risk of cancer in individuals with LFS is greater than 70% in males and greater than 90% in females. Some patients with LFS develop multiple primary cancers during their lifetime, and guidelines have been established for screening these patients. Whole-body MRI is the preferred modality for annual screening of these patients. The management guidelines for patients with LFS vary, as these individuals are more susceptible to developing radiation-induced cancers-for example, women with LFS and breast cancer are treated with total mastectomy instead of lumpectomy with radiation to the breast. The authors review the role of imaging, imaging guidelines, and imaging features of tumors in the setting of LFS. ©RSNA, 2024 Supplemental material is available for this article.

1 December 2020 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
CGChristopher Gange
Christopher Gange
JPJay K. Pahade
Jay K. Pahade
ICIsabel Cortopassi
Isabel Cortopassi
ABAnna S. Bader
Anna S. Bader
JBJamal Bokhari
Jamal Bokhari
ARAmi N. Rubinowitz
Ami N. Rubinowitz
Purpose To develop a technique that allows portable chest radiography to be performed through the glass door of a patient’s room in the emergency department. Materials and Methods A retrospective r...